Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 4, 2011, Pages 957-969

  Yamaguchi, Yukie ^a   Yasuoka, Hidekata ^a   Stolz, Donna B ^a   Feghali Bostwick, Carol A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Caveolin 1; Extracellular matrix; Fibrosis; Insulin like growth factor binding protein 5

Indexed keywords

CAVEOLIN 1; CELL EXTRACT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL; ARTICLE; C57BL MOUSE; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL NUCLEUS; CYTOPLASM; ENDOCYTOSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FIBROBLAST; FIBROSIS; HUMAN; INTRACELLULAR SPACE; METABOLISM; MOUSE; PATHOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT; ULTRASTRUCTURE;

ANIMALS; CAVEOLIN 1; CELL COMPARTMENTATION; CELL EXTRACTS; CELL NUCLEUS; CYTOPLASM; ENDOCYTOSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FIBROBLASTS; FIBROSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INTRACELLULAR SPACE; MICE; MICE, INBRED C57BL; PROTEIN BINDING; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS;

MUS;

EID: 79955654537     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01063.x     Document Type: Article

References (51)

1. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000; 43: 2437-44.
2. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998; 157: 1301-15.
3. Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc. 2006; 3: 383-8.
4. Liu X, Wu H, Byrne M, et al. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol. 1995; 130: 227-37.
5. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007; 117: 557-67.
6. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol. 1955; 1: 445-58.
7. Schlegel A, Pestell RG, Lisanti MP. Caveolins in cholesterol trafficking and signal transduction: implications for human disease. Front Biosci. 2000; 5: D929-37.
8. Parton RG, Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic. 2003; 4: 724-38.
9. Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell. 2001; 106: 403-11.
10. Kasper M, Reimann T, Hempel U, et al. Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol. 1998; 109: 41-8.
11. Tourkina E, Gooz Pal, Pannu J, et al. Opposing effects of protein kinase Cα and protein kinase Ce{open} on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem. 2005; 280: 13879-87.
12. Galdo FD, Sotgia F, de Almeida CJ, et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum. 2008; 58: 2854-65.
13. Wang XM, Zhang Y, Kim HP, et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med. 2006; 203: 2895-906.
14. Razani B, Zhang XL, Bitzer M, et al. Caveolin-1 regulates transforming growth factor (TGF)-β/Smad signaling through an interaction with TGF-β type I receptor. J Biol Chem. 2001; 276: 6727-38.
15. Kim S, Lee Y, Seo JE, et al. Caveolin-1 increases basal and TGF-β1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell signal. 2008; 20: 1313-9.
16. Tourkina E, Richard M, Gööz P, et al. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L843-61.
17. Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in Caveolin-1 gene-disrupted mice. Science. 2001; 293: 2449-52.
18. Le Lay S, Kurzchalia TV. Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta. 2005; 1746: 322-33.
19. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995; 16: 3-34.
20. Xu Q, Li S, Zhao Y, et al. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells. Circ Res. 2004; 94: E46-54.
21. Miyakoshi N, Richman C, Kasukawa Y, et al. Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest. 2001; 107: 73-81.
22. Andress DL, Loop SM, Zapf J, et al. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun. 1993; 195: 25-30.
23. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor β-1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem. 1997; 272: 12181-8.
24. Schedlich LJ, Young TF, Firth SM, et al. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem. 1998; 273: 18347-52.
25. Schedlich LJ, Le Page SL, Firth SM, et al. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J Biol Chem. 2000; 275: 23462-70.
26. Andress DL. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am J Physiol. 1998; 274: E744-50.
27. Feghali CA, Wright T-M. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum. 1999; 42: 1451-7.
28. Pilewski JM, Liu L, Henry AC, et al. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol. 2005; 166: 399-407.
29. Yasuoka H, Zhou Z, Pilewski JM, et al. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am J Pathol. 2006; 169: 1633-42.
30. Yasuoka H, Hsu E, Ruiz XD, et al. The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms. Am J Pathol. 2009; 175: 605-15.
31. Yasuoka H, Jukic DM, Zhou Z, et al. Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis. Arthritis Rheum. 2006; 54: 3001-10.
32. Yasuoka H, Yamaguchi Y, Feghali-Bostwick CA. The pro-fibrotic factor IGFBP-5 induces lung fibroblasts and mononuclear cell migration. Am J Respir Cell Mol Biol. 2009; 41: 179-88.
33. Yasuoka H, Larregina AT, Yamaguchi Y, et al. Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins. Open Rheumatol J. 2008; 2: 17-22.
34. Kim HP, Wang X, Galbiati F, et al. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J. 2004; 18: 1080-9.
35. Stolz DB, Zamora R, Vodovotz Y, et al. Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology. 2002; 36: 81-93.
36. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991; 19: 2499.
37. Jurgeit A, Berlato C, Obrist P, et al. Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic. 2007; 8: 1815-28.
38. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol. 1995; 50: 191-224.
39. Okamoto T, Schlegel A, Scherer PE, et al. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem. 1998; 273: 5419-22.
40. Couet J, Li S, Okamoto T, et al. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997; 272: 6525-33.
41. Lee KW, Liu B, Ma L, et al. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem. 2004; 279: 469-76.
42. Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem. 1999; 274: 8858-64.
43. Hopkins CR, Trowbridge IS. Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J Cell Biol. 1983; 97: 508-21.
44. Hsia E, Richardson TP, Nugent MA. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling. J Cell Biochem. 2003; 88: 1214-25.
45. Hsieh T, Gordon RE, Clemmons DR, et al. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF binding proteins. J Biol Chem. 2003; 278: 42886-92.
46. Koedam JA, Hoogerbrugge CM, Van Buul-Offers SC. Insulin-like growth factor binding protein-3 and -5 form sodium dodecyl sulfate-stable multimers. Biochem Biophys Res Commun. 1997; 240: 707-14.
47. Feng Y, Venema VJ, Venema RC, et al. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem Biophys Res Commun. 1999; 256: 192-7.
48. Chrétien A, Piront N, Delaive E, et al. Increased abundance of cytoplasmic and nuclear caveolin 1 in human diploid fibroblasts in H(2)O(2)-induced premature senescence and interplay with p38alpha(MAPK). FEBS Lett. 2008; 582: 1685-92.
49. Dittmann K, Mayer C, Kehlbach R, et al. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer. 2008; 7: 69.
50. Jones JI, Gockerman A, Busby WH Jr, et al. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J Cell Biol. 1993; 121: 679-87.
51. Patel HH, Zhang S, Murray F, et al. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J. 2007; 21: 2970-9.